Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
International Journal of Molecular Sciences|July 1, 2020
Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human OsteosarcomaMartina Godel, Deborah Morena, Preeta Ananthanarayanan, et al.
The American Journal of Pathology|March 14, 2002
The expression of ccn3(nov) gene in musculoskeletal tumorsMaria Cristina Manara, Bernard Perbal, Stefania Benini, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Journal of Medicinal Chemistry|April 28, 2016
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug ResistanceKonstantin Chegaev, Barbara Rolando, Daniela Cortese, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2)Daniela Rossi, Mariangela Urbano, Alice Pedrali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stabilityDaniela Rossi, Annamaria Marra, Pietro Picconi, et al.
Cells|May 13, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. <i>Cells</i> 2020, <i>9</i>, 647Dimas Carolina Belisario, Muhlis Akman, Martina Godel, et al.
Cancer Research|August 19, 2007
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signalingLara Cantiani, Maria Cristina Manara, Cinzia Zucchini, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2009
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survivalGiuseppe Toffoli, Paola Biason, Antonio Russo, et al.
International Journal of Molecular Sciences|July 1, 2020
Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human OsteosarcomaMartina Godel, Deborah Morena, Preeta Ananthanarayanan, et al.
The American Journal of Pathology|March 14, 2002
The expression of ccn3(nov) gene in musculoskeletal tumorsMaria Cristina Manara, Bernard Perbal, Stefania Benini, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Journal of Medicinal Chemistry|April 28, 2016
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug ResistanceKonstantin Chegaev, Barbara Rolando, Daniela Cortese, et al.
Bioorganic & Medicinal Chemistry|January 5, 2010
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2)Daniela Rossi, Mariangela Urbano, Alice Pedrali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
Bioorganic & Medicinal Chemistry|March 19, 2013
Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stabilityDaniela Rossi, Annamaria Marra, Pietro Picconi, et al.
Cells|May 13, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. <i>Cells</i> 2020, <i>9</i>, 647Dimas Carolina Belisario, Muhlis Akman, Martina Godel, et al.
Cancer Research|August 19, 2007
Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signalingLara Cantiani, Maria Cristina Manara, Cinzia Zucchini, et al.
Pageof 16